1. Wu CC, Pai TY, Hsiao FY, Shen LJ, Wu FL. The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations. Ther Drug Monit. 2016 Oct;38(5):587-92. (SCI)

2. Chan DC, Chang CH, Lim LC, Brnabic AJ, Tsauo JY, Burge R, Hsiao FY, Jin L, Gürbüz S, Yang RS. Association between teriparatide treatment persistence and adherence, and fracture incidence in Taiwan: analysis using the National Health Insurance Research Database. Osteoporos Int. 2016 Sep;27(9):2855-65. (SCI)

3. Chen LJ, Hsiao FY#, Shen LJ, Wu FL, Tsay W, Hung CC, Lin SW. Use of Hypoprothrombinemia-Inducing Cephalosporins and the Risk of Hemorrhagic Events: A Nationwide Nested Case-Control Study. PLoS One. 2016 Jul 27;11(7):e0158407. (SCI)

4. Lin ZF, Wang CY, Shen LJ, Hsiao FY†, Lin Wu FL. Statin Use and the Risk for Incident Diabetes Mellitus in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Population-Based Retrospective Cohort Study in Taiwan. Can J Diabetes. 2016 Jun;40(3):264-9. (SCI)

5. Hsieh PH, Lu WH, Pai TY, Gau CS, Wu CY, Hsiao FY*. Characterization of patients with duplicated z-hypnotic use: A population-based study in Taiwan. J Clin Geron Geriatr. 2016 Jun;7(2):60-63.

6. Lu WH, Lee WJ, Chen LK, Hsiao FY*. Comparisons of annual health care utilization, drug consumption, and medical expenditure between the elderly and general population in Taiwan. J Clin Geron Geriatr. 2016 Jun;7(2):44-47.

7. Lin CH, Hsiao FY#, Liu YB, Gau SS, Wang CC, Shen LJ. Antidepressants and Valvular Heart Disease: A Nested Case-Control Study in Taiwan. Medicine (Baltimore). 2016 Apr;95(14):e3172. (SCI)

8. Lu WH, Chiou ST, Chen LK, Hsiao FY*. Functional and Mental Health Outcomes of the Joint Effects of Spousal Health: The Potential Threats of "Concordant Frailty". J Am Med Dir Assoc. 2016 Apr 1;17(4):324-30. (SCI)

9. Lu HM, Wei CP, Hsiao FY*. Modeling healthcare data using multiple-channel latent Dirichlet allocation. J Biomed Inform. 2016 Apr;60:210-23. (SCI)

10. Wang CY, Fu SH, Wang CL, Chen PJ, Wu FL, Hsiao FY*. Serotonergic antidepressant use and the risk of fracture: a population-based nested case-control study. Osteoporos Int. 2016 Jan;27(1):57-63. (SCI)

11. Wang CC, Chen YH, Xiao ML, Hsiao FY*. Curriculum of Doctor of Pharmacy at School of Pharmacy, National Taiwan University: Pharmacoeconomics and Pharmacy Administration. Formosan J Med. 2016 Jan;20(1):48-53.

12. Hsieh SY, Chen YW, Chen JJ, Ke WM, Huang WI, Hsiao FY. Investigation of novel oral anticoagulants-related hemorrhagic risks using national adverse drug reaction reporting system in Taiwan. Formosan J Med. 2016 Jan;20(1):16-24.

13. Chen HL, Shen LJ, Wei CP, Lu HM, Hsiao FY*. Decision to adopt medical technology under the National Health Insurance System in Taiwan: case study of new molecular targeted drugs among non-small cell lung cancer patients. J Eval Clin Pract. 2015 Oct;21(5):808-16. (SCI)

14. Chen HL, Hsiao FY*. Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study. Pharmacoepidemiol Drug Saf. 2015 Aug;24(8):841-8.(SCI)

15. Hsu CI, Hsiao FY#, Wu FL, Shen LJ. Adherence and medication utilisation patterns of fixed-dose and free combination of angiotensin receptor blocker/thiazide diuretics among newly diagnosed hypertensive patients: a population-based cohort study. Int J Clin Pract. 2015 Jul;69(7):729-37. (SCI)

16. Huang WF, Chang LC, Kao YH, Wen YW, Hsiao FY, Peng LN, Tsai YW, Chen LK. Prolonged risk of subtrochanteric and diaphyseal femur fractures after discontinuing alendronate treatment: A nationwide nested case-control study in Taiwan. J Clin Gerol Geriatr. 2015 Jun;6(2):54-58. (SCI)

17. Chen HL, Hsu WW, Hsiao FY*. Changes in prevalence of diabetic complications and associated healthcare costs during a 10-year follow-up period among a nationwide diabetic cohort. J Diabetes Complications. 2015 May-Jun;29(4):523-8. (SCI)

18. Hsiao FY, Peng LN, Wen YW, Liang CK, Wang PN, Chen LK. Care needs and clinical outcomes of older people with dementia: a population-based propensity score-matched cohort study. PLoS One. 2015 May 8;10(5):e0124973. (SCI)

19. Chew TW, Gau CS, Wen YW, Shen LJ, Mullins CD, Hsiao FY*. Epidemiology, clinical profile and treatment patterns of venous thromboembolism in cancer patients in Taiwan: a population-based study. BMC Cancer. 2015 Apr 17;15:298. (SCI)

20. Lu WH, Wen YW, Chen LK, Hsiao FY*. Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study. CMAJ. 2015 Mar 3;187(4):E130-7. (SCI)

21. Fang HY, Hsiao FY#, Huang HC, Lin YS, Chen CY, Shieh SH, Chen PR, Chen CK, Chien CR. Cost and effectiveness of video-assisted thoracoscopic surgery for clinical stage I non-small cell lung cancer: a population-based analysis. J Thorac Dis. 2014 Dec;6(12):1690-6. (SCI)

22. Huang WF, Chou HC, Tsai YW, Hsiao FY*. Safety of deferasirox: a retrospective cohort study on the risks of gastrointestinal, liver and renal events. Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1176-82.(SCI)

23. Chou HC, Lin SW, Chen WW, Ke WM, Chao PH, Hsiao FY*. Monitoring liver function among patients who initiated anti-tuberculosis drugs in Taiwan, 2000-2011. Int J Tuberc Lung Dis. 2014 Oct;18(10):1245-51.(SCI)

24. Chen HL, Hsiao FY*. Risk of hospitalization and healthcare cost associated with Diabetes Complication Severity Index in Taiwan's National Health Insurance Research Database. J Diabetes Complications. 2014 Sep-Oct;28(5):612-6.(SCI)

25. Chew DW, Lin SW, Wu FL, Kao TW, Hsiao FY*. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Following Use of Allopurinol and Relapse during Rapid Tapering of Corticosteroid. Formosa Journal of Clinical Pharmacy. 2014 Sep;22(3):149-157.(SCI)

26. Lin WT, Wen YW, Chien CR, Gau CS, Chiang SC, Hsiao FY*. Suboptimal duration of granulocyte colony-stimulating factor use and chemotherapy-induced neutropenia in women diagnosed with breast cancer. Clin Ther. 2014 Sep 1;36(9):1287-94.(SCI)

27. Hsiao FY, Peng LN, Lin MH, Chen LK. Dose-responsive effect of psychotropic drug use and subsequent dementia: a nationwide propensity score matched case-control study in Taiwan. J Am Med Dir Assoc. 2014 Jul;15(7):509-13.(SCI)

28. Chen SC, Hsiao FY*, Lee CM, Hsu WW, Gau CS. Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome. BMC Cardiovasc Disord. 2014 Feb 18;14:21.(SCI)

29. Lin CF, Shen LJ, Hsiao FY, Gau CS, Wu FL. Sex Differences in the Treatment and Outcome of Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention: A Population-Based Study. J Womens Health (Larchmt). 2014 Mar;23(3):238-45.(SCI)

30. Hsiao FY*, Hsu WW. Epidemiology of post-transplant malignancy in Asian renal transplant recipients: a population-based study. Int Urol Nephrol. 2014 Apr;46(4):833-8.(SCI)

31. Hsiao FY*, Hsieh PH, Gau CS. Ten-year trend in prescriptions of z-hypnotics among the elderly: A nationwide, cross-sectional study in Taiwan. J Clin Gerol Geriatr 2013;4:37-41

32. Hsieh PH, Hsiao FY*. Risk of heart failure associated with dopamine agonists: a nested case-control study. Drugs Aging. 2013 Sep;30(9):739-45 (SCI)

33. Hsiao FY*, Hsieh PH, Huang WF, Tsai YW, Gau CS. Risk of bladder cancer in diabetic patients treated with rosiglitazone or pioglitazone: a nested case-control study. Drug Saf. 2013 Aug;36(8):643-9.(SCI)

34. Hsieh PH, Hsiao FY#, Gau SS, Gau CS. Use of antipsychotics and risk of cerebrovascular events in schizophrenic patients: a nested case-control study. J Clin Psychopharmacol. 2013 Jun;33(3):299-305.(SCI)

35. Tsai YW, Hsiao FY, Wen YW, Kao YH, Chang LC, Huang WF, Peng LN, Liu CL, Chen LK. Clinical outcomes of vertebroplasty or kyphoplasty for patients with vertebral compression fractures: a nationwide cohort study. J Am Med Dir Assoc. 2013; 14:41-7.(SCI)

36. Mullins CD, Hsiao FY, Onukwugha E, Pandya NB, Hanna N. Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients. Cancer. 2012; 118:3173-3181.(SCI)

37. Hsiao FY, Mullins CD, Huang WF. Economic evaluation of thiazolidinediones as add-on therapy for treatment of type 2 diabetic patients in the Taiwanese National Health Insurance System. J Food Drug Anal. 2012; 20:431-437.

38. Lin CF, Wu FLL, Lin SW, Bai CH, Chan DC, Gau CS, Hsiao FY, Shen LJ. Age, Dementia, and Care Patterns after Admission for Acute Coronary Syndrome: An Analysis from a Nationwide Cohort under the National Health Insurance Coverage. Drugs Aging. 2012; 29:819-28.(SCI)

39. Chen YM, Chen DY, Chen LK, Tsai YW, Chang LC, Huang WF, Chen LK, Liu CL, Chen YT, Hsiao FY. Alendronate and risk of esophageal cancer: a nationwide population-based study in Taiwan. J Am Geriatr Soc. 2011; 59:2379-2381.(SCI)

40. Hsiao FY, Huang WF, Chen YM, Wen YW, Kao YH, Chen LK, Tsai YW. Hip and subtrochanteric or diaphyseal femoral fractures in alendronate users: a 10-year, nationwide retrospective cohort study in Taiwanese women. Clin Ther. 2011; 33:1659-1667.(SCI)

41. Wu FL, Hsiao FY, Bai CH, Shen LJ, Lin CF, Gau CS. Impact of ezetimibe coadministered with statins on cardiovascular events following acute coronary syndrome: a 3-year population-based retrospective cohort study in Taiwan. Clin Ther. 2011; 33:1120-1131.(SCI)

42. Hsiao FY, Mullins CD, Onukwugha E, Pandya N, Hanna N. Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data. J Am Geriatr Soc. 2011; 59:1717-1723.(SCI)

43. Hsiao FY, Mullins CD, Wen YW, Huang WF, Chen PF, Tsai YW. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome. Pharmacoepidemiol Drug Saf. 2011; 20:1043-1049.(SCI)

44. Hsiao FY, Tsai YW, Wen YW, Kuo KN, Tsai CR, Huang WF. Effect of Helicobacter pylori eradication therapy on risk of hospitalization for a major ulcer event. Pharmacotherapy. 2011; 31:239-247.(SCI)

45. Wen YW, Tsai YW, Huang WF, Hsiao FY, Chen PF. The potentially inappropriate prescription of new drug: thiazolidinediones for patients with type II diabetes in Taiwan. Pharmacoepidemiol Drug Saf. 2011; 20:20-29.(SCI)

46. Tsai YW, Wen YW, Huang WF, Chen PF, Kuo KN, Hsiao FY. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding. J Gastroenterol. 2011; 46:39-45.(SCI)

47. Lin CF, Hsiao FY, Shen LJ*. Impact of ezetimibe co-administered with statins on cardiovascular events following acute coronary syndrome: a 3-year population-based retrospective cohort study in Taiwan. Clin Ther. 2011; 33:2092 (Letter to the Editor).(SCI)

48. Hsiao FY*, Mullins CD. The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study. Diabetologia. 2010; 53(3):489-96(SCI)

49. Hsiao FY*, Tsai YW, Huang WF. Price regulation, new entry, and information shock on pharmaceutical market in Taiwan: a nationwide data-based study from 2001 to 2004. BMC Health Serv Res. 2010; 10:218(SCI)

50. Hsiao FY*, Tsai YW, Wen YW, Chen PF, Chou HY, Chen CH, Kuo KN, Huang WF. Relationship between cumulative dose of thiazolidinediones and clinical outcomes in type 2 diabetic patients with history of heart failure: a population-based cohort study in Taiwan. Pharmacoepidemiol Drug Saf. 2010; 19(8):786-91(SCI)

51. Huang WF, Tsai YW, Wen YW, Hsiao FY, Kuo KN, Tsai CR. Osteoporosis treatment and atrial fibrillation: alendronate versus raloxifene. Menopause. 2010; 17:57-63.

52. Hsiao FY*, Yen YH, Lee CN, Huang WF, Chen HY. Prevention and monitoring of hepatotoxicity among Patients Receiving antituberculosis medications. Taiwan Pharmaceutical Journal. 2009; 61:107-114

53. Hsiao FY*, Tsai YW, Huang WF, Wen YW, Chen PF, Chang PY, Kuo KN. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding. Clinical Therapeutics 2009; 31(9):2038-47(SCI)

54. Hsiao FY*, Tsai YW, Huang WF. Changes in physicians practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: a retrospective study of physician-patient pairs in Taiwan. Clinical Therapeutics 2009; 31(11):2618-2627(SCI)

55. Hsiao FY*, Huang WF, Wen YW, Chen PF, Kuo KN, Tsai YW. Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473,000 patients using the National Health Insurance database in Taiwan. Drug Safety 2009; 32(8):675-690(SCI)

56. Hsiao FY*, Yang CL, Huang YT, Huang WF. Using Taiwan national health insurance research databases for pharmacoepidemiology research. Journal of Food and Drug Analysis 2007; 15(2):99-108(SCI)

57. Huang WF, Tsai YW, Hsiao FY*, Liu WC. Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan. BMC Public Health 2007; 7(56):(SCI)

58. Hsiao FY*, Lee JA, Huang WF, Chen SM, Chen HY. Evaluation of drug safety-related knowledge, attitude, and practice among college students in Taiwan. American Journal of Pharmaceutical Education 2006; 70(2):30-43(SCI)

59. Huang WF, Hsiao FY*, Tsai YW, Wen YW, Shih YT. Cardiovascular events associated with long-term celecoxib, rofecoxib, and meloxicam use in Taiwan: An observational study. Drug Safety 2006; 29(3):261-272(SCI)

60. Huang WF, Hsiao FY*, Tsai YW, Wen YW. Cardiovascular events associated with the use of Four NSAIDs (etodolac, nabumetone, ibuprofen, naproxen) and Celecoxib in Taiwan: A population-based observational study. Clinical Therapeutics 2006; 28(11):1827-1836(SCI)